Message Font: Serif | Sans-Serif
No. of Recommendations: 1
SA (6/30/14)The Good, The Bad, And ugly by Sierra Monolith Investments, who owns both, made several interesting observations as follows - (1) MNK knows exactly what the acquisition entails; the smear campaign against QCOR & MNK is not working; NYT article has false statements and supposedly noted (?) lab tests to deter facts do not have all the facts(2) Both have new Institutional holders - QCOR 9.917,231 & MNK 60,398,978 - surely they have investigated and worthy of investing (3) QCOR R&D investment increased 84% to $19.9 Million (have 7 clinical tests in progress (4) Graphical illustrations portraying short interest relationships between PPS and outstanding shares - since April 2014, short interest and QCOR price per share are both increasing ??? Is this the way it is suppose to work??? This logical report convinces me to hold QCOR follow those who put their money on facts not those short in the shorts (our kids called hem snuggies)
Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.